HIV a discussion paper for first year university medical students.

Authors Avatar

HIV – a discussion paper for first year university medical students.

The Problem

Between 25-30% of babies born to HIV-infected women will become infected. Research has shown a higher infection rate in infants when umbilical cord blood contains more HIV protein even though this is too large to pass through the placenta. The placenta prevents most HIV viral DNA from reaching the foetus, but small tears allow the virus to be transmitted during delivery. As the baby is delivered, it comes into contact with the mother’s blood and bodily fluids, allowing HIV to attack the baby’s cells. Also, T-helper cells transferred from the mother to the child during breast feeding may have become infected by viral particles. (see Appendix for biology of the HIV virus)

A possible solution – anti-HIV drugs

Anti-retroviral drugs – these are used not to cure but to fight the disease, lowering the viral load. They can increase life expectancy significantly but may also induce toxic side effects. Drugs must be introduced before the immune system is irreversibly damaged but not so early that toxicity becomes rapidly dangerous. Combination drugs are used to reduce drug resistance but must not reduce treatment impact or increase toxic effects. There are three main purposes of HIV treatment during pregnancy: to reduce the toxic influence of the mother’s treatment on the foetus (currently, little is known about the potential of antiretroviral drugs to cause birth defects); to reduce the mother’s viral load and disease progression; and to prevent the baby being infected with HIV.

To see just how effective these drugs were, a randomized, double-blind, placebo-controlled trial of the antiretroviral zidovudine was conducted (http://hivinsite.ucsf.edu.). Zidovudine, a nucleoside reverse transcriptase inhibitor, disrupts the process where the viral DNA combined with the host DNA is transcribed to produce RNA. It reduces the risk of maternal-infant HIV transmission. Thirteen infants in the zidovudine group and 40 in the placebo group were HIV-infected: a 67.5% reduction in HIV transmission. This source seems very reliable, with many precautions taken in testing to ensure accuracy. Other accounts of zidovudine and HIV transmission in pregnancy support these results (see http://www.avert.org/pregnancy.htm) and it is accepted as effective enough to use as mainstream treatment.

Protease inhibitors - HIV protease, an enzyme that speeds up the action of the virus, can be inhibited to slow disease progression. Protease binds to the cutting site of an inactive viral polyprotein and then cuts it into active proteins. The inhibitor disables the protease enzyme by imitating the cutting site.

Join now!

Ethical, Economic & Social Issues

AIDS results from the specific damage HIV inflicts on the immune system, and is the collection of illnesses suffered as a consequence. These symptoms may not develop until long after infection, and a sufferer might not know they have the virus, but can still transmit it to others. In my view, governments should attempt more vigorous screening, preventing thousands from unknowingly transmitting HIV through intercourse and pregnancy. This is undoubtedly one of the most prominent ways in which HIV is spread.

However, HIV test results are ...

This is a preview of the whole essay